Patent ID: 7811551

Claim:
A method for in vivo imaging of a disease or condition selected from the group consisting of: breast, skin, colorectal, pancreatic, prostate, lung and ovarian cancer; atherosclerosis; rheumatoid arthritis; gingivitis; arteriovenous malformations; astrocytomas; choriocarcinomas; glioblastomas; gliomas; hemangiomas; hepatomas; hyperplastic endometrium; ischemic myocardium; endometriosis; Kaposi sarcoma; macular degeneration; melanoma; neuroblastomas; occluding peripheral artery disease; osteoarthritis; psoriasis; retinopathy; scleroderma; seminomas and ulcerative colitis which comprises the step of administering a compound of formula (I): wherein R 2 is wherein b is an integer of from 0 to 10; R 3 is a C 1-4 alkylene or C 2-4 alkenylene bridge; W 1 is absent or represents a spacer moiety which is a C 1-30 hydrocarbyl group optionally including 1 to 10 heteroatoms selected from oxygen, nitrogen, and sulphur, and is preferentially derived from glutaric and/or succinic acid and/or a polyethyleneglycol based unit and/or a unit of Formula: Z 1 is an antineoplastic agent, a chelating agent or a reporter moiety.